Lymphomas
A Phase 2, Multicenter, Single-arm Study of Zanubrutinib (BGB-3111) in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Intolerant of Prior Treatment with Ibrutinib (BGB-3111-215)
- Details
ClinicalTrials.gov ID:
NCT03206918
Diagnosis Type:
NA
USOR Number:
- Address
520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001